Tigre-pTRE2-LSL-ZGX!EmGFP-2A-ZGX!TagGFP2-2A-ZGX!hrGFP-CAG-LSL-tTA2
Nomenclature
C57BL/6Smoc-Igs7em1(2Xlns-pTRE2-Lox2272-stop-Lox2272-ZGX!emGFP-T2A-ZGX!TagGFP2-P2A-ZGX!hrGFP-Wpre-pA-2Xlns-pCAG-LoxP-stop-LoxP-tTA2-Wpre-pA)Smoc
Cat. NO.
NM-KI-200288
Strain State
Embryo cryopreservation
Model Description
A 2Xlns-pTRE2-Lox2272-stop-Lox2272-ZGX!EmGFP-T2A-ZGX!TagGFP2-P2A-ZGX!hrGFP- Wpre-pA-2Xlns-pCAG-LoxP-stop-LoxP-tTA2-Wpre-pA expression cassette was knocked into the TIGRE locus via CRISPR/Cas9 mediated recombination.
*Literature published using this strain should indicate: Tigre-pTRE2-LSL-ZGX!EmGFP-2A-ZGX!TagGFP2-2A-ZGX!hrGFP-CAG-LSL-tTA2 mice (Cat. NO. NM-KI-200288) were purchased from Shanghai Model Organisms Center, Inc..
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more
